Clinical Trials Directory

Trials / Conditions / Juvenile Idiopathic Arthritis

Juvenile Idiopathic Arthritis

163 registered clinical trials studyying Juvenile Idiopathic Arthritis26 currently recruiting.

StatusTrialSponsorPhase
WithdrawnPharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
NCT04585711
Duke UniversityPhase 1
Enrolling By InvitationMethotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthri
NCT07386587
University of Child Health Sciences and Children's Hospital, LahorePhase 3
RecruitingRegulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated
NCT07243782
Novartis Pharmaceuticals
RecruitingPain in Juvenile Arthritis
NCT07217782
Washington University School of MedicineN/A
Not Yet RecruitingAssessment of Composite Inflammatory Ratios in Juvenile Idiopathic Arthritis and Their Association With Diseas
NCT07083466
Sohag University
Not Yet RecruitingProspective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Act
NCT06431750
Novartis Pharmaceuticals
RecruitingFeasibility of a Diet Intervention for Juvenile Arthritis
NCT06474546
The Hospital for Sick ChildrenN/A
Enrolling By InvitationMesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases
NCT06888973
National Institute of Blood and Marrow Transplant (NIBMT), PakistanPhase 1 / Phase 2
RecruitingDynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA
NCT06870045
Istanbul University - Cerrahpasa
CompletedAssessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Fam
NCT06697028
Istanbul University - Cerrahpasa
RecruitingOptimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Tria
NCT06653634
Oslo University HospitalPhase 4
CompletedFitness Integrative Training for Pediatric Rheumatology Disorders
NCT06556992
Children's Hospital Medical Center, CincinnatiN/A
RecruitingM3-JIA: Making Mindfulness Matter for Children With JIA
NCT06376149
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
Not Yet RecruitingAnalysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Diseas
NCT06413563
Sohag University
RecruitingCore Stabilization Training in Juvenile Spondyloarthropathy
NCT06546293
Istanbul University - CerrahpasaN/A
RecruitingStudy to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
NCT06222034
Alfasigma S.p.A.Phase 1
Not Yet RecruitingImaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
NCT05984758
Institute of Child HealthN/A
CompletedExercise Programs on Gait in Children JIA
NCT06356350
Istanbul University - CerrahpasaN/A
CompletedEfficiency of Supervised Exercise Program Versus Mobile-Based Exercise Program in Juvenile Idiopathic Arthriti
NCT06193681
Istanbul University - CerrahpasaN/A
CompletedComparative Study of Leflunomide Plus Methotrexate Versus Methotrexate Monotherapy in Refractory Polyarticular
NCT07428551
Bangladesh Medical UniversityPhase 4
RecruitingVirtual Self-Management Program for JIA
NCT06184100
University of CalgaryN/A
UnknownImmersive Virtual Reality Exergaming Program in Adolescents Diagnosed With Juvenile Idiopathic Arthritis
NCT06176846
Istanbul University - CerrahpasaN/A
UnknownFibrinogen to Albumin Ratio and C-reactive Protein to Albumin Ratio in Juvenile Idiopathic Arthritis
NCT06024486
Assiut University
RecruitingStudy of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Ad
NCT05609630
AbbViePhase 3
UnknownInterest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Fe
NCT05572424
Centre Hospitalier Universitaire de BesanconN/A
RecruitingPersonalized Estimates of Response and Severity Outcomes in Newly-diagnosed JIA
NCT05310799
University of British ColumbiaN/A
Active Not RecruitingRecombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
NCT05879419
University of Sao Paulo General HospitalPhase 4
CompletedEffect of Pulsed Magnetic Field Versus Low Level Laser Therapy on Functional Performance in Children With Juve
NCT06226012
Shrouk Abd Elmohsen Taha Basiony ElnhrawyN/A
UnknownCoenzyme Q10 in Juvenile Idiopathic Arthritis Patients
NCT05871086
Nourhan ElsherifPhase 2 / Phase 3
CompletedEffects of Telemonitoring-supported Game-based Home Exercises in Juvenile Idiopathic Arthritis
NCT05837247
Istanbul University - CerrahpasaN/A
RecruitingPharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis
NCT07517575
R-Pharm International, LLCPhase 2
CompletedSelf-Management Supported Telerehabilitation in Children and Adolescents With Juvenile Idiopathic Arthritis
NCT06115954
Pamukkale UniversityN/A
CompletedTransition to Adulthood Through Coaching and Empowerment
NCT05570617
McMaster UniversityN/A
CompletedTurkish Reliability and Validity of FOPQC-SF
NCT05439434
Pamukkale UniversityN/A
UnknownAccess to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rh
NCT05696340
University Hospital, Clermont-Ferrand
CompletedTransition to Adulthood Through Coaching and Empowerment in Rheumatology
NCT05545839
McMaster UniversityN/A
CompletedTurkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)
NCT05436301
Kutahya Health Sciences University
UnknownMandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects
NCT05467579
University of GenovaN/A
UnknownMSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
NCT05545098
Assiut University
CompletedInspiratory Muscle Training in Juvenile Idiopathic Arthritis
NCT05482633
Izmir Katip Celebi UniversityN/A
CompletedStructured 3D Exercise and the Conventional Exercise Program for Scoliosis in Children With Rheumatic Disease
NCT05377086
Biruni UniversityN/A
UnknownSarcopenia in Children
NCT05291416
University Tunis El Manar
TerminatedHost-microbiota-environment Interactions
NCT05176795
University Hospital, Clermont-Ferrand
RecruitingClinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis
NCT06007456
IRCCS Burlo Garofolo
UnknownEffectiveness and Feasibility of a Home-based Exercise Program for Adolescents With Juvenile Idiopathic Arthri
NCT05114343
University of Sao Paulo General HospitalN/A
CompletedAccommodating Variable-Resistance Training in Patients With Juvenile Idiopathic Arthritis
NCT05805969
Cairo UniversityN/A
RecruitingConception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma
NCT04902807
Institut National de la Santé Et de la Recherche Médicale, France
RecruitingDevelopment of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
NCT04833465
Children's National Research Institute
CompletedRapid Diagnostic Test for Septic Arthritis
NCT04460144
Assistance Publique - Hôpitaux de Paris
UnknownSurvey on the Expectations of Adolescents With Juvenile Idiopathic Arthritis (JIA) Regarding Knowledge and Com
NCT04791189
University Hospital, Clermont-Ferrand
UnknownAn Investigation Into the Relationship Between Dietary Intake and Health-related Quality of Life in Children a
NCT04903067
Oxford Brookes University
CompletedHip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis
NCT04775225
Sohag UniversityPhase 3
CompletedSpine Deformities in Juvenile Idiopathic Arthritis
NCT04664231
Biruni University
CompletedThe Role of Aquatic-Based Plyometric Exercises for Patients With Juvenile Idiopathic Arthritis
NCT05304832
Cairo UniversityN/A
CompletedStrategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA).
NCT04614311
Oslo University HospitalPhase 4
CompletedGenicular Nerve Block in Juvenile Idiopathic Arthritis
NCT04687930
Sohag UniversityPhase 4
CompletedThe Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affe
NCT04671524
Istanbul University - CerrahpasaN/A
UnknownDrug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment
NCT04407923
University Hospital, Brest
UnknownClinical and Biochemical Evaluation of Dental and Periodontal Conditions in Children With Juvenile Idiopathic
NCT05217277
Marmara University
CompletedSleep Innovations for Preschoolers With Arthritis (SIPA): Developing and Pilot Testing of a Self-Management In
NCT04354337
University of WashingtonN/A
UnknownRole of Ultrasound Imaging in Diagnosis of Juvenile Idiopathic Arthritis
NCT04178837
Assiut University
CompletedSleep Shared-Management Intervention for Children With Juvenile Idiopathic Arthritis
NCT04066205
University of WashingtonN/A
CompletedPreventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
NCT03841357
Duke UniversityPhase 3
UnknownAssessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy
NCT04167488
Centre Hospitalier Universitaire de BesanconN/A
UnknownYoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis
NCT03833609
Children's Hospital of Eastern OntarioN/A
CompletedThe Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis
NCT04169828
University of British ColumbiaN/A
Completed(1,3)-Béta-D-Glucan Levels at Diagnosis of Juvenile Idiopathic Arthritis and Its Correlation With Activity's D
NCT03984669
Centre Hospitalier Universitaire, AmiensN/A
RecruitingHealth and Exercise Response in Children With Chronic and Auto-immune Pathologies
NCT03913962
University Hospital, Clermont-FerrandN/A
UnknownClinical Study of Genakumab for Injection in Chinese Healthy Volunteers
NCT04337437
Changchun GeneScience Pharmaceutical Co., Ltd.Phase 1
RecruitingA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthriti
NCT03773965
Eli Lilly and CompanyPhase 3
CompletedInterleukin 33 in Juvenile Idiopathic Arthritis Patients
NCT03835624
Benha University
CompletedA Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthrit
NCT03773978
Eli Lilly and CompanyPhase 3
WithdrawnChronic Non-inflammatory Pains in Rheumatopediatrics
NCT03740347
Assistance Publique - Hôpitaux de Paris
CompletedThe Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Resu
NCT03833271
University of PecsEARLY_Phase 1
CompletedLow-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis
NCT05031104
Cairo UniversityN/A
CompletedBiomarkers in Pediatric Inflammatory Rheumatic Diseases
NCT07356804
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
RecruitingUCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
NCT06560606
The Hospital for Sick Children
RecruitingA Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthr
NCT02991469
SanofiPhase 2
CompletedA Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT03301883
Hoffmann-La RochePhase 4
CompletedDetermination of Exercise Behavior in Patients With Juvenile Idiopathic Arthritis
NCT03731520
Saime Nilay ArmanN/A
CompletedYellow Fever Vaccine in Patients With Rheumatic Diseases
NCT03430388
University of Sao Paulo General HospitalN/A
CompletedProbiotic Treatment in Juvenile Idiopathic Arthritis (JIA)
NCT03092427
Assistance Publique - Hôpitaux de ParisN/A
UnknownTreatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis
NCT04205500
Uppsala UniversityN/A
CompletedPsychosocial Outcomes and Transition Readiness in JIA
NCT04216498
Sheffield Children's NHS Foundation Trust
CompletedTreatment Tapering in JIA With Inactive Disease
NCT02840175
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedRepresentation and Medication Use in Juvenile Idiopathic Arthritis
NCT03892135
University Hospital, Montpellier
CompletedThe iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis
NCT03116763
The Hospital for Sick ChildrenN/A
CompletedIntranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population
NCT03069638
University of OuluPhase 4
UnknownStudy of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacome
NCT03006991
Guangzhou Women and Children's Medical Center
UnknownOxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopath
NCT02977416
University Hospital, Clermont-FerrandN/A
CompletedTherapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthrit
NCT02824978
University Hospital, Brest
CompletedAn Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticu
NCT02776735
SanofiPhase 2
CompletedA Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies
NCT03769558
Bristol-Myers Squibb
CompletediCanCope With Pain: Usability and Feasibility Testing of a Smartphone Application to Manage Pain in Youth With
NCT02764346
The Hospital for Sick ChildrenN/A
CompletedEfficacy Study Of Tofacitinib In Pediatric JIA Population
NCT02592434
PfizerPhase 3
CompletedFatigue and Sleep in Children and Adolescents With Juvenile Idiopathic Arthritis: A Cross-Sectional Study
NCT03618680
Istanbul University
CompletedJointly Managing JIA Online: An Internet-based Psycho-educational Game for Children With JIA and Their Parents
NCT02610166
The Hospital for Sick ChildrenN/A
CompletedPatient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
NCT02524340
Children's Hospital Medical Center, Cincinnati
UnknownCellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Disea
NCT02502539
University Hospital, Clermont-FerrandN/A
TerminatedMassage Therapy in Juvenile Idiopathic Arthritis
NCT02218580
McGill University Health Centre/Research Institute of the McGill University Health CentreN/A
CompletedARTEMIS Synovial Markers in Arthritis Childhood
NCT02505828
University Hospital, MontpellierN/A
UnknownPatientSpot Formerly Known as ArthritisPower
NCT03840928
Global Healthy Living Foundation
CompletedBiomarkers in Saliva in Children With Juvenil Idiopathic Arthritis
NCT02223195
Folktandvården Stockholms län AB
Completed"Medikidz Explain JIA Comic Book- Hebrew"
NCT02191722
Rabin Medical CenterN/A
CompletedExtension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administrat
NCT02165345
Hoffmann-La RochePhase 1
CompletedHuman Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
NCT02052167
medac GmbHEARLY_Phase 1
UnknownAnti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Imm
NCT02116504
Assistance Publique - Hôpitaux de ParisN/A
CompletedWeb-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness
NCT02453880
Stanford UniversityN/A
CompletedUnderstanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood
NCT02528435
University of Aarhus
CompletedEffective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
NCT02030613
Assistance Publique - Hôpitaux de ParisN/A
RecruitingMedical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916
Université Catholique de Louvain
CompletedA Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
NCT01904292
Hoffmann-La RochePhase 1
CompletedEfficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat A
NCT01835470
Bristol-Myers SquibbPhase 3
CompletedA Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juveni
NCT01904279
Hoffmann-La RochePhase 1
CompletedVirtual Peer-to-Peer (VP2P) Support Mentoring for Juvenile Idiopathic Arthritis (JIA): A Pilot RCT
NCT01986400
The Hospital for Sick ChildrenN/A
CompletedA Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory
NCT01734382
Hoffmann-La RochePhase 4
UnknownEfficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
NCT02024334
Mashhad University of Medical SciencesPhase 4
CompletedLong-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
NCT01500551
PfizerPhase 2 / Phase 3
CompletedPharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
NCT01513902
PfizerPhase 1
CompletedAn Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopa
NCT01727986
Hoffmann-La RochePhase 3
Active Not RecruitingAn Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668
Bristol-Myers Squibb
CompletedA Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2
NCT01455701
Hoffmann-La RochePhase 1
TerminatedStudy of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
NCT01694264
Seoul National University HospitalPhase 3
CompletedEfficacy of Web-based Pain Self-management for Adolescents With Juvenile Idiopathic Arthritis
NCT01541917
Children's Mercy Hospital Kansas CityPhase 3
CompletedOpen-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopath
NCT01563185
AmgenPhase 4
CompletedA Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis
NCT01673919
Hoffmann-La RochePhase 3
TerminatedAn Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis
NCT01575769
Hoffmann-La RochePhase 3
CompletedA Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis
NCT01667471
Hoffmann-La RochePhase 3
CompletedCost of Care for Juvenile Idiopathic Arthritis
NCT01469897
The Cleveland Clinic
TerminatedOpen-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arth
NCT01557452
ItalfarmacoN/A
UnknownPharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
NCT01399281
Istituto Giannina Gaslini
UnknownStudy of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
NCT01436019
Blood Transfusion Centre of Slovenia
UnknownSleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
NCT01434082
University of Washington
CompletedAssessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers
NCT01358383
AstraZenecaPhase 1
UnknownPrediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
NCT02218892
Malin Collin
UnknownWithdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
NCT01287715
Erasmus Medical CenterPhase 4
TerminatedA Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA
NCT01230827
Janssen Research & Development, LLCPhase 3
UnknownSafety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
NCT01151644
University of Sao PauloPhase 4
CompletedA Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
NCT00988221
Hoffmann-La RochePhase 3
CompletedThe CARRA Registry
NCT01697254
Duke University
CompletedEnbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
NCT01145352
Pfizer
CompletedDetermining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
NCT00792233
Children's Hospital Medical Center, CincinnatiPhase 4
CompletedActive Juvenile Idiopathic Arthritis (JIA) Compassionate Use
NCT00775437
AbbVie (prior sponsor, Abbott)Phase 3
WithdrawnEffect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
NCT00836394
Children's Hospital of Eastern OntarioN/A
No Longer AvailableRequest for Single Patient IND for Compassionate/Emergency Use of Tocilizumab
NCT00862758
University of Oklahoma
CompletedImmune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
NCT00815282
N.M. WulffraatPhase 4
CompletedSafety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and You
NCT00534495
Montefiore Medical CenterPhase 2
CompletedInternet Self-Management Program With Telephone Support for Adolescents With Arthritis
NCT01011179
The Hospital for Sick ChildrenN/A
CompletedJuvenile Idiopathic Arthritis (JIA) Registry
NCT00783510
AbbVie
UnknownMagnetic Resonance Imaging (MRI) in Asymptomatic Patients With Juvenile Idiopathic Arthritis (JIA)
NCT00800371
University Hospital Tuebingen
CompletedA Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA
NCT00642460
Hoffmann-La RochePhase 3
UnknownMagnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthr
NCT00801593
University Hospital Tuebingen
CompletedSpine Quantitative Computed Tomography (QCT)
NCT00762879
Children's Hospital of Philadelphia
Completed23-valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients Under Anti-TNF Therapy
NCT02196480
University of Sao PauloPhase 4
CompletedImmunogenicity of HPV Vaccine in Immunosuppressed Children
NCT02263703
The University of New South WalesPhase 3
CompletedTrial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
NCT00443430
Seattle Children's HospitalPhase 4
CompletedOHRQoL Evaluation After Functional Therapy in JIA Patients
NCT03008681
University of MessinaN/A
CompletedAggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
NCT01015547
Helsinki University Central HospitalPhase 3
CompletedPEAK Study (Physical Exercise and Activity in Kids)
NCT00213187
The Hospital for Sick ChildrenPhase 2
CompletedRetrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopath
NCT02784808
Hoffmann-La Roche
CompletedEfficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
NCT00420251
Ludwig-Maximilians - University of MunichPhase 3
CompletedCyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
NCT00404482
St. Franziskus Hospital
UnknownPRINTO (the Paediatric Rheumatology International Trials Organisation)
NCT00415935
Institute of Child Health